With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class rare disease drug DIAG723. The Massachusetts-based biotech, which develops ...
Dying of brain cancer in modern London, a teenager is transported to an Italianate world in his dreams—and to a city that mirrors Renaissance Venice. PW said, "The novel will likely intrigue more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results